Boston Scientific (NYSE:BSX) announced today that it completed the nearly $1.1 billion acquisition of the global surgical business of Lumenis. Marlborough, Massachusetts–based Boston Scientific announced in March that it entered into a definitive agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire Lumenis’ surgical business, which develops and commercializes energy-based medical solutions. […]
Lumenis Ltd.
DTW Podcast: Can AI, advanced imaging and robotics ‘democratize’ surgery?
A new generation of digital surgery systems will level surgeons’ playing field — giving them artificial intelligence, robotic tools, and other assistive technologies. In three interviews in this week’s DeviceTalks Weekly Podcast, leaders from Asensus, ActivSurgical and Memic explain how their systems will improve surgeon performance, reduce errors, and deliver the “democratization” of surgical robotics. […]
Boston Scientific to acquire Lumenis surgical business for $1.07B
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire the global surgical business of Lumenis for nearly $1.1 billion. Marlborough, Mass.–based Boston Scientific, entered into the agreement with an affiliate of Baring Private Equity Asia (BPEA) to acquire the privately-held company’s global surgical business, which develops and commercializes energy-based medical […]
Report: Lumenis could sell for $1B
Investment firm Baring Private Equity Asia is considering a takeover of medical laser company Lumenis in a deal that could be worth more than $1 billion, according to a report by Bloomberg News. The report is the latest news swirling about Lumenis, which was sold to the Hong-Kong-based XIO group in 2015 for approximately $510 […]
Report: Asian PE player eyes Lumenis for $1B
Another private equity firm, this time out of Asia, is said to be in the running for a $1 billion takeover of Israeli medical laser maker Lumenis. In 2018 another PE shop, CVC Capital Partners, was reportedly mulling a $900 million takeover of Lumenis, which was sold to the Hong-Kong-based XIO group in 2015 for about […]
Report: PE firm CVC in talks to acquire Lumenis in deal worth up to $900m
Private equity firm CVC Capital Partners is considering a take over of medical laser company Lumenis in a deal that could be worth up to $900 million, according to a report from CTech. The two parties are reportedly in advanced negotiations that would put the Israel-based medical and cosmetic laser biz under new ownership. Lumenis […]
Lumenis’ XIO buyout closes
Lumenis said it completed its $510 million take over by Hong-Kong based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. Shareholders will receive a […]
Lumenis shareholders approve $510m XIO take over
Lumenis shareholders approved the company’s $510 million sale to Hong Kong-based XIO group, according to an SEC filing posted yesterday. Lumenis makes energy-based medical devices for surgical, ophthalmological and aesthetic applications. Yokneam, Israel-based Lumenis will become a wholly-owned subsidiary of an Israel-based company that is indirectly wholly-owned by XIO, according to the SEC filing. In June, Lumenis […]
Hong Kong’s Xio to pay $510m for Lumenis
Lumenis (NSDQ:LMNS) said today that it agreed to a $510 million acquisition bid from a Hong Kong-based “alternative investments” shop. Yokneam, Israel-based Lumenis, which raised $75 million in an initial public offering last year, was said in February to be in talks about a buyout by Chinese conglomerate Fosun for nearly $500 million. Today Lumenis said Xio Group put […]
CAH top suitor for JNJ’s Cordis unit | The week in medtech M&A
Report: Lumenis in talks to be acquired by Fosun for $480M
Lumenis Ltd., which raised nearly $100 million through an initial public offering on NASDAQ last year, is in talks to be acquired by Chinese conglomerate Fosun for nearly $500 million, according to the Israeli financial newspaper Calcalist.
